Lipid-based combinational drug delivery systems
Authors:
- Nupur ShrivastavaNSNupur Shrivastava
- Ankit ParikhAPAnkit Parikh
- Aiswarya ChaudhuriACAiswarya Chaudhuri
- Javed AliJAJaved Ali
- Sanjula BabootaSBSanjula Baboota
- Sanjay GargSanjay Garg
- 1 January 2021
- book chapter
- Published by Elsevier
- p. 259-305
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Trans-ferulic acid-based solid lipid nanoparticles and their antioxidant effect in rat brain microsomesColloids and Surfaces B: Biointerfaces, 2013
- The use of multi-target drugs in the treatment of neurodegenerative diseasesExpert Review of Clinical Pharmacology, 2011
- Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to ClinicCritical Reviews™ in Therapeutic Drug Carrier Systems, 2009
- Liposomal nanomedicinesExpert Opinion on Drug Delivery, 2007
- Preparation, Characterization, and Biological Analysis of Liposomal Formulations of Vincristine2005
- Study of the toxicity of a new lipid complex formulation of amphotericin BJournal of Antimicrobial Chemotherapy, 2003
- Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systemsEuropean Journal of Pharmaceutical Sciences, 2000
- Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- Combination Therapy For Type 2 DiabetesEndocrine Practice, 1999
- Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanismEuropean Journal of Pharmaceutics and Biopharmaceutics, 1998